Archive - February 2020
KTE-X19 bags FDA Priority Review in mantle cell lymphoma
New ‘score’ developed to measure multimorbidity
Novartis pulls ahead of Merck in MET-positive lung cancer race
Long Term Plan to ‘boost’ nurse apprenticeships
SMC approves first two ‘ultra-orphan’ pathway meds
Exelixis bounces back with new prostate cancer data
Botox strength bolsters Allergan ahead of AbbVie takeover
Engaging the New HCP in the Digital World
